Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

标题
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 27, Issue 8, Pages 1268-1274
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2009-02-10
DOI
10.1200/jco.2008.17.5984

向作者/读者发起求助以获取更多资源

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now